Michel de Rosen in PR Newswire (press release) 2006 was a year of tremendous execution and advancement throughout the company, including the commercial and clinical organizations,commented Mr. de Rosen. "I can confirm that our 2006 net Vancocin(R) sales will be within our guidance...